323 related articles for article (PubMed ID: 25818677)
1. Gout after living kidney donation: a matched cohort study.
Lam NN; McArthur E; Kim SJ; Prasad GV; Lentine KL; Reese PP; Kasiske BL; Lok CE; Feldman LS; Garg AX; ;
Am J Kidney Dis; 2015 Jun; 65(6):925-32. PubMed ID: 25818677
[TBL] [Abstract][Full Text] [Related]
2. Fracture risk in living kidney donors: a matched cohort study.
Garg AX; Pouget J; Young A; Huang A; Boudville N; Hodsman A; Adachi JD; Leslie WD; Cadarette SM; Lok CE; Monroy-Cuadros M; Prasad GV; Thomas SM; Naylor K; Treleavan D;
Am J Kidney Dis; 2012 Jun; 59(6):770-6. PubMed ID: 22472209
[TBL] [Abstract][Full Text] [Related]
3. Gestational hypertension and preeclampsia in living kidney donors.
Garg AX; Nevis IF; McArthur E; Sontrop JM; Koval JJ; Lam NN; Hildebrand AM; Reese PP; Storsley L; Gill JS; Segev DL; Habbous S; Bugeja A; Knoll GA; Dipchand C; Monroy-Cuadros M; Lentine KL;
N Engl J Med; 2015 Jan; 372(2):124-33. PubMed ID: 25397608
[TBL] [Abstract][Full Text] [Related]
4. Risk of Nephrectomy in Previous Living Kidney Donors.
Ordon M; Welk B; McArthur E; Lam NN; Lentine KL; Nguan C; Garg AX;
Transplantation; 2016 Jun; 100(6):1313-7. PubMed ID: 26683516
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular disease and hypertension risk in living kidney donors: an analysis of health administrative data in Ontario, Canada.
Garg AX; Prasad GV; Thiessen-Philbrook HR; Ping L; Melo M; Gibney EM; Knoll G; Karpinski M; Parikh CR; Gill J; Storsley L; Vlasschaert M; Mamdani M;
Transplantation; 2008 Aug; 86(3):399-406. PubMed ID: 18698242
[TBL] [Abstract][Full Text] [Related]
6. Perioperative mortality and long-term survival following live kidney donation.
Segev DL; Muzaale AD; Caffo BS; Mehta SH; Singer AL; Taranto SE; McBride MA; Montgomery RA
JAMA; 2010 Mar; 303(10):959-66. PubMed ID: 20215610
[TBL] [Abstract][Full Text] [Related]
7. Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial.
Goicoechea M; Garcia de Vinuesa S; Verdalles U; Verde E; Macias N; Santos A; Pérez de Jose A; Cedeño S; Linares T; Luño J
Am J Kidney Dis; 2015 Apr; 65(4):543-9. PubMed ID: 25595565
[TBL] [Abstract][Full Text] [Related]
8. Opportunities for improving medication use and monitoring in gout.
Singh JA; Hodges JS; Asch SM
Ann Rheum Dis; 2009 Aug; 68(8):1265-70. PubMed ID: 18701554
[TBL] [Abstract][Full Text] [Related]
9. Risk of end-stage renal disease following live kidney donation.
Muzaale AD; Massie AB; Wang MC; Montgomery RA; McBride MA; Wainright JL; Segev DL
JAMA; 2014 Feb; 311(6):579-86. PubMed ID: 24519297
[TBL] [Abstract][Full Text] [Related]
10. Risk of serious gastrointestinal bleeding in living kidney donors.
Thomas SM; Lam NN; Huang A; Nash DM; Prasad GV; Knoll GA; Koval JJ; Lentine KL; Kim SJ; Alam A; Lok CE; Treleaven DJ; Garg AX;
Clin Transplant; 2014 May; 28(5):530-9. PubMed ID: 24579904
[TBL] [Abstract][Full Text] [Related]
11. A prospective controlled study of living kidney donors: three-year follow-up.
Kasiske BL; Anderson-Haag T; Israni AK; Kalil RS; Kimmel PL; Kraus ES; Kumar R; Posselt AA; Pesavento TE; Rabb H; Steffes MW; Snyder JJ; Weir MR
Am J Kidney Dis; 2015 Jul; 66(1):114-24. PubMed ID: 25795073
[TBL] [Abstract][Full Text] [Related]
12. Impact of allopurinol on risk of myocardial infarction.
Grimaldi-Bensouda L; Alpérovitch A; Aubrun E; Danchin N; Rossignol M; Abenhaim L; Richette P;
Ann Rheum Dis; 2015 May; 74(5):836-42. PubMed ID: 24395556
[TBL] [Abstract][Full Text] [Related]
13. Duration of Living Kidney Transplant Donor Evaluations: Findings From 2 Multicenter Cohort Studies.
Habbous S; Arnold J; Begen MA; Boudville N; Cooper M; Dipchand C; Dixon SN; Feldman LS; Goździk D; Karpinski M; Klarenbach S; Knoll GA; Lam NN; Lentine KL; Lok C; McArthur E; McKenzie S; Miller M; Monroy-Cuadros M; Nguan C; Prasad GVR; Przech S; Sarma S; Segev DL; Storsley L; Garg AX;
Am J Kidney Dis; 2018 Oct; 72(4):483-498. PubMed ID: 29580662
[TBL] [Abstract][Full Text] [Related]
14. Gout, allopurinol use, and heart failure outcomes.
Thanassoulis G; Brophy JM; Richard H; Pilote L
Arch Intern Med; 2010 Aug; 170(15):1358-64. PubMed ID: 20696962
[TBL] [Abstract][Full Text] [Related]
15. Gout after living kidney donation: correlations with demographic traits and renal complications.
Lam NN; Garg AX; Segev DL; Schnitzler MA; Xiao H; Axelrod D; Brennan DC; Kasiske BL; Tuttle-Newhall JE; Lentine KL
Am J Nephrol; 2015; 41(3):231-40. PubMed ID: 25896309
[TBL] [Abstract][Full Text] [Related]
16. [Quality of life of living kidney donor: a national report].
Briançon S; Germain L; Baudelot C; Bannay A; Virion JM; Thuong M
Nephrol Ther; 2011 Jul; 7 Suppl 1():S1-39. PubMed ID: 21907160
[TBL] [Abstract][Full Text] [Related]
17. Risk of kidney stones with surgical intervention in living kidney donors.
Thomas SM; Lam NN; Welk BK; Nguan C; Huang A; Nash DM; Prasad GV; Knoll GA; Koval JJ; Lentine KL; Kim SJ; Lok CE; Garg AX;
Am J Transplant; 2013 Nov; 13(11):2935-44. PubMed ID: 24102981
[TBL] [Abstract][Full Text] [Related]
18. Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
Becker MA; Schumacher HR; Wortmann RL; MacDonald PA; Eustace D; Palo WA; Streit J; Joseph-Ridge N
N Engl J Med; 2005 Dec; 353(23):2450-61. PubMed ID: 16339094
[TBL] [Abstract][Full Text] [Related]
19. End-stage renal disease among living-kidney donors: single-center experience.
Wafa EW; Refaie AF; Abbas TM; Fouda MA; Sheashaa HA; Mostafa A; Abo El Ghar MI; Ghoneim MA
Exp Clin Transplant; 2011 Feb; 9(1):14-9. PubMed ID: 21605018
[TBL] [Abstract][Full Text] [Related]
20. Short- and long-term outcomes of kidney donors: a report from Tunisia.
Helal I; Abdallah TB; Ounissi M; Tahar G; Cherif M; Boubaker K; Karoui C; Hamida FB; Adberrahim E; El Younsi F; Kheder A; Sfaxi M; Derouiche A; Chebil M; Hachicha J; Mehiri MN; Skhiri H; Elmay M; Harzallah K; Elmanaa MJ; Hmida J
Saudi J Kidney Dis Transpl; 2012 Jul; 23(4):853-9. PubMed ID: 22805410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
